BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15488110)

  • 1. Cross-validation of the alcohol and cannabis use measures in the Global Appraisal of Individual Needs (GAIN) and Timeline Followback (TLFB; Form 90) among adolescents in substance abuse treatment.
    Dennis ML; Funk R; Godley SH; Godley MD; Waldron H
    Addiction; 2004 Nov; 99 Suppl 2():120-8. PubMed ID: 15488110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are clinical impressions of adolescent substance use accurate?
    Wilson CR; Sherritt L; Gates E; Knight JR
    Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teenagers are right--parents do not know much: an analysis of adolescent-parent agreement on reports of adolescent substance use, abuse, and dependence.
    Fisher SL; Bucholz KK; Reich W; Fox L; Kuperman S; Kramer J; Hesselbrock V; Dick DM; Nurnberger JI; Edenberg HJ; Bierut LJ
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1699-710. PubMed ID: 17010137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site.
    Newcombe DA; Humeniuk RE; Ali R
    Drug Alcohol Rev; 2005 May; 24(3):217-26. PubMed ID: 16096125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thirty-month relapse trajectory cluster groups among adolescents discharged from out-patient treatment.
    Godley SH; Dennis ML; Godley MD; Funk RR
    Addiction; 2004 Nov; 99 Suppl 2():129-39. PubMed ID: 15488111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the quick drinking screen and the alcohol timeline followback with outpatient alcohol abusers.
    Roy M; Dum M; Sobell LC; Sobell MB; Simco ER; Manor H; Palmerio R
    Subst Use Misuse; 2008 Dec; 43(14):2116-23. PubMed ID: 18825590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use.
    Robinson SM; Sobell LC; Sobell MB; Leo GI
    Psychol Addict Behav; 2014 Mar; 28(1):154-62. PubMed ID: 23276315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the timeline follow-back in the assessment of adolescent smoking.
    Lewis-Esquerre JM; Colby SM; Tevyaw TO; Eaton CA; Kahler CW; Monti PM
    Drug Alcohol Depend; 2005 Jul; 79(1):33-43. PubMed ID: 15943942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST).
    Humeniuk R; Ali R; Babor TF; Farrell M; Formigoni ML; Jittiwutikarn J; de Lacerda RB; Ling W; Marsden J; Monteiro M; Nhiwatiwa S; Pal H; Poznyak V; Simon S
    Addiction; 2008 Jun; 103(6):1039-47. PubMed ID: 18373724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Injury Distress Index: development and validation.
    Victorson DE; Enders CK; Burnett KF; Ouellette EA
    Arch Phys Med Rehabil; 2008 Oct; 89(10):1893-902. PubMed ID: 18929018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment setting and baseline substance use severity interact to predict patients' outcomes.
    Tiet QQ; Ilgen MA; Byrnes HF; Harris AH; Finney JW
    Addiction; 2007 Mar; 102(3):432-40. PubMed ID: 17298651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective validation of substance abuse severity measures from administrative data.
    McCamant LE; Zani BG; McFarland BH; Gabriel RM
    Drug Alcohol Depend; 2007 Jan; 86(1):37-45. PubMed ID: 16806738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between anxiety and alcohol versus cannabis abuse disorders among adolescents in primary care settings.
    Low NC; Lee SS; Johnson JG; Williams JB; Harris ES
    Fam Pract; 2008 Oct; 25(5):321-7. PubMed ID: 18753288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties of DSM assessments of illicit drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Lynskey MT; Agrawal A
    Psychol Med; 2007 Sep; 37(9):1345-55. PubMed ID: 17407621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The developmental antecedents of illicit drug use: evidence from a 25-year longitudinal study.
    Fergusson DM; Boden JM; Horwood LJ
    Drug Alcohol Depend; 2008 Jul; 96(1-2):165-77. PubMed ID: 18423900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
    Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
    Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports.
    Wurst FM; Dürsteler-MacFarland KM; Auwaerter V; Ergovic S; Thon N; Yegles M; Halter C; Weinmann W; Wiesbeck GA
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1552-7. PubMed ID: 18616663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral assessment of gambling: an application of the timeline followback method.
    Weinstock J; Whelan JP; Meyers AW
    Psychol Assess; 2004 Mar; 16(1):72-80. PubMed ID: 15023094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence.
    Kendler KS; Myers J; Prescott CA
    Arch Gen Psychiatry; 2007 Nov; 64(11):1313-20. PubMed ID: 17984400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.